MIIM
ADMA icon

Mesirow Institutional Investment Management’s ADMA Biologics ADMA Stock Holding History

Mesirow Institutional Investment Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$13.4M Sell
782,451
-219,452
-22% -$4.13M 1.03% 55
2024
Q3 		$20M Sell
1,001,903
-753,552
-43% -$11.7M 1.53% 5
2024
Q2 		$19.6M Sell
1,755,455
-853,827
-33% -$7.16M 1.72% 2
2024
Q1 		$17.2M Buy
+2,609,282
New +$14.3M 1.53% 7

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Mesirow Institutional Investment Management's ADMA Position: Q4 2024 in Review

Mesirow Institutional Investment Management reduced its ADMA Biologics (ADMA) stake by 22% in Q4 2024, selling an estimated $4.13M and leaving 782,451 shares worth $13.4M. The position accounts for 1.03% of the portfolio, ranked #55.

Mesirow Institutional Investment Management first reported a position in ADMA in Q1 2024 and has held it in 4 quarters since. The position peaked at $20M in Q3 2024. 321 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

  • Mesirow Institutional Investment Management held 782,451 shares of ADMA Biologics worth $13.4M as of Q4 2024.
  • Mesirow Institutional Investment Management sold 219,452 ADMA Biologics shares in Q4 2024, an estimated $4.13M.
  • ADMA Biologics made up 1.03% of Mesirow Institutional Investment Management's portfolio in Q4 2024, its #55 holding.
  • Mesirow Institutional Investment Management first reported a position in ADMA Biologics in Q1 2024 and has held it in 4 quarters since.
  • Mesirow Institutional Investment Management's ADMA Biologics position peaked at $20M in Q3 2024.
  • 321 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.